In an experimental model of COPD, Sokar et al. showed that rats treated with a combination of dexamethasone (Dex) and losartan (Los) demonstrated inhibited disease progression, and the MDA levels significantly decreased by 50.75% and the SOD levels increased by 45.22% [74]. This evidence concerns the gene SOD1 and chronic obstructive pulmonary disease.